Qure.ai, a medical technology firm, receives $65 million to develop AI-based disease detection products
Qure.ai, founded in 2016 by Prashant Warier, provides AI-powered medical imaging diagnostics. It uses to diagnose brain damage, chest illnesses, and other conditions.
The startup claims its system can detect clinically important aberrant injuries from X-rays, CT Scans, and MRIs in less time than clinicians
Medtech startup Qure.ai raised $65 million (INR 543 crore) in a Series D fundraising round headed by Lightspeed Venture Partners and 360 ONE Asset Management.
Merck Global Health Innovation Fund and Kae Capital joined current investors Novo Holdings, Health Quad, and TeamFund in the round
According to Bloomberg, the company intends to utilize the cash to expand in the US and other regions, strengthen its GenAI foundation models, and fund acquisitions.
Prashanth Warier, Qure.AI's founders and CEO told Bloomberg that AI is assisting in the removal of healthcare bottlenecks
The Indian medtech, diagnosis, and treatment business is changing significantly due to digital health adoption, AI integration, and wearable technologies.
Last month, Visit Health received INR 250 Cr (almost $29.8 Mn) from PB Fintech's affiliate, Docprime Technologies.